<DOC>
	<DOCNO>NCT01169038</DOCNO>
	<brief_summary>Sarcoidosis granulomatous disease molecular immunologic association mycobacteria continue strengthen . The investigator interested conduct proof-of-concept investigation effect antibiotics sarcoidosis resolution . The investigator hypothesize pulmonary sarcoidosis improve faster patient give antimycobacterial therapy , addition standard therapy .</brief_summary>
	<brief_title>Investigation Efficacy Antibiotics Pulmonary Sarcoidosis</brief_title>
	<detailed_description />
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Sarcoidosis , Pulmonary</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Ethambutol</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Subjects sarcoidosis enrol define . 1 . Patients sarcoidosis define ATS/ERS/WASOG statement sarcoidosis define clinical presentation consistent sarcoidosis , well biopsy find granuloma , alternative cause granuloma , tuberculosis . 2 . Evidence parenchymal disease chest radiograph ( Stage II , III IV ) Stage I disease chest radiograph evidence abnormal spirometry . . Subjects concurrent extrapulmonary sarcoidosis , particularly skin eye involvement , enrol . 3 . FVC &gt; =45 % &lt; =80 % predict normal value screen . 4 . If female , subject either childbearing potential , defined postmenopausal least 1 year surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy ) , use one follow method birth control duration study 90 day study completion : 1. condom , sponge , foam , jelly , diaphragm , intrauterine device 2. contraceptive ( oral parenteral ) three month prior study drug administration 3. vasectomized sole partner 4 . Females childbearing potential must negative urine pregnancy test screen visit . 1 . No consent/inability obtain consent . 2 . Age le 18 year age . 3 . Inability draw blood . 4 . ALT AST &gt; 5 time upper limit normal ( ULN ) 5 . Pregnancy breast feed . 6 . Allergy macrolides , quinolones rifamycins . 7 . Visual Impairment define differentiate color per personal history . 8 . Family personal history long QT syndrome . 9 . Patients receive another interventional investigational drug sarcoidosis within 30 day prior dose 10 . Use investigational medication within past 28 day prior study enrollment . 11 . Subject hospitalized infection receive IV antibiotic within previous 2 month prior baseline . 12 . Subject history tuberculosis anytime close contact person active tuberculosis within previous 6 month , persistent active infection require hospitalization treatment IV antibiotic , IV antiretrovirals , IV antifungal within 30 day baseline , OR oral antibiotic , antiviral , antifungal purpose treat infection , within 14 day baseline . 13 . Subject active infection require systemic antibiotic time screen 14 . Subject history listeriosis , treat untreated tuberculosis , exposure individual tuberculosis . 15 . Have diagnosis significant respiratory disorder sarcoidosis would complicate evaluation response treatment 16 . Patients otherwise unsuitable participation opinion investigator . 17 . No smoking past one year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>sarcoidosis</keyword>
	<keyword>mycobacteria</keyword>
	<keyword>lung</keyword>
	<keyword>pulmonary</keyword>
	<keyword>radiographic improvement</keyword>
</DOC>